| ■ 영문 제목 : Substance Abuse Treatment Market Size, Share & Trends Analysis Report By Treatment Type (Tobacco/Nicotine & Vaping, Alcohol), By End-use (Rehabilitation Centers, Clinics, Hospitals), By Region, And Segment Forecasts, 2023 - 2030
|
 | ■ 상품코드 : GRV23MR038
■ 조사/발행회사 : Grand View Research
■ 발행일 : 2023년 2월
■ 페이지수 : 130
■ 작성언어 : 영어
■ 보고서 형태 : PDF
■ 납품 방식 : E메일 (납기:3일)
■ 조사대상 지역 : 세계
■ 산업 분야 : 의료
|
■ 판매가격 / 옵션
(부가세 10% 별도)
| Single User (1인 열람용) | USD5,950 ⇒환산￦8,032,500 | 견적의뢰/주문/질문 |
| Multi User (5인 열람용) | USD6,950 ⇒환산￦9,382,500 | 견적의뢰/주문/질문 |
| Global/corporate License (기업 열람용) | USD8,950 ⇒환산￦12,082,500 | 견적의뢰/구입/질문 |
※가격옵션 설명
- 납기는 즉일~2일소요됩니다. 3일이상 소요되는 경우는 별도표기 또는 연락드립니다.
- 지불방법은 계좌이체/무통장입금 또는 카드결제입니다.
|
Grand View Research사의 본 조사 보고서는 글로벌 약물 남용 치료 시장 규모가 2023년부터 2030년 사이에 CAGR 9.05% 증가하여, 2030년에는 205.1억 달러에 달할 것으로 전망하고 있습니다. 본 자료는 글로벌 약물 남용 치료 시장을 조사대상으로 하여, 조사 방법 및 범위, 개요, 산업 전망, 경쟁 현황, 치료 종류별 (담배/니코틴/VAPE, 알코올, 마리화나, 합성 카나비노이드, 기타) 분석, 최종 용도별 (병원, 진료소, 재활 센터, 기타) 분석, 지역별 (북미, 유럽, 아시아 태평양, 중남미, 중동 및 아프리카) 분석, 기업 정보 등의 항목을 수록하고 있습니다. 덧붙여 본 리포트는 Teva Pharmaceutical Industries Ltd., Abbott, GSK Plc., F. Cipla Inc., Lilly (Eli Lilly And Company), Novartis Ag, Sun Pharmaceutical Industries Ltd.,, Dr. Reddy's Laboratories Ltd., Viatris Inc., AstraZeneca 등의 기업 정보가 포함되어 있습니다.
・조사 방법 및 범위
・개요
・산업 전망
・경쟁 현황
・글로벌 약물 남용 치료 시장 규모 : 치료 종류별
- 담배, 니코틴, VAPE 중독 치료의 시장 규모
- 알코올 중독 치료의 시장 규모
- 마리화나중독 치료의 시장 규모
- 합성 카나비노이드 중독 치료의 시장 규모
- 기타 약물 남용 치료의 시장 규모
・글로벌 약물 남용 치료 시장 규모 : 최종 용도별
- 병원에서 사용되는 약물 남용 치료의 시장 규모
- 진료소에서 사용되는 약물 남용 치료의 시장 규모
- 재활 센터에서 사용되는 약물 남용 치료의 시장 규모
- 기타 최종 용도에 사용되는 약물 남용 치료의 시장 규모
・글로벌 약물 남용 치료 시장 규모 : 지역별
- 북미의 약물 남용 치료 시장 규모
- 유럽의 약물 남용 치료 시장 규모
- 아시아 태평양의 약물 남용 치료 시장 규모
- 중남미의 약물 남용 치료 시장 규모
- 중동과 아프리카의 약물 남용 치료 시장 규모
・기업 정보 |
■ 보고서 개요Substance Abuse Treatment Market Growth & Trends
The global substance abuse treatment market size is expected to reach USD 20.51 billion by 2030, expanding at a CAGR of 9.05% from 2023 to 2030, according to a new report by Grand View Research, Inc. The growth is attributed to the increasing demand for therapeutic options as a result of the rising prevalence of substance abuse cases. For instance, according to the UNODCWorld Drug Report, in 2020, 284 million individuals aged between 15 and 64 years used drugs globally. Alcohol and tobacco are among the most extensively consumed psychoactive substances. They are also regarded as the most harmful psychoactive substances globally and are the leading causes of morbidity and mortality. The tobacco epidemic alone is one of the world’s most prominent public health concerns.
According to the WHO estimates, globally, there are 1.3 billion tobacco consumers, of which more than 8 million people die annually due to its consumption. Over 7 million tobacco deaths are the consequence of direct tobacco use, while about 1.2 million deaths are caused by passive smoking, where non-smokers are exposed to environmental tobacco smoke. Government initiatives to enable and advance healthcare settings to combat the rising concerns of substance abuse will drive market growth. For instance, in March 2020, researchers at Columbia University set up a new center due to the growing crisis associated with opioid and other substance use disorders. Various global initiatives spreading awareness about addiction treatment are among the major factors driving the industry growth.
For instance, the WHO celebrates World No Tobacco Day on May 31st each year. In addition, in June 2021, DC Health launched the public education campaign, MyRecoveryDC, to help provide access to treatments and recovery services for substance abuse. In October 2022, Qnovia raised USD 17 million to fight against nicotine addiction. Furthermore, key players are focusing on collaborations and partnerships to develop novel therapeutics for drug addiction treatment and maintain their competitive position in the market. For instance, in November 2022, Opiant Pharmaceuticals, Inc. entered into a definitive agreement with Indivior PLC to strengthen its position as the leader in addiction treatment. The acquisition is expected to give rights of Opiant’s pipeline product, OPNT003, an opioid overdose treatment, after its approval and launch.
Players are entering the drug addiction treatment market attributable to enhanced revenue generation possibilities in the treatment of drug addiction. For instance, in January 2023, Hikma announced the launch of its prefilled Naloxone Hydrochloride Injection, for the treatment of opioid overdose in the U.S. The growing need for effective drug addiction treatment in the U.S. and enhanced government support is expected to boost demand for drug addiction treatment.
Substance Abuse Treatment Market Report Highlights
• The tobacco/nicotine & vaping segment dominated the industry in 2022 due to the high public awareness regarding the adverse effects associated with its consumption
• The alcohol segment is expected to register the fastest growth rate over the forecast period owing to the high consumption rate associated with alcohol
• The hospitals segment dominated the industry in 2022 due to the ease of availability of various drug addiction treatments in hospital settings
• North America was the dominant regional market in 2022 due to the increased substance abuse cases along with high investments to provide effective treatments
■ 보고서 목차Table of Contents
Chapter 1 Substance Abuse Treatment Market: Methodology And Scope
1.1 Market Segmentation
1.1.1 Segment Scope
1.1.2 Regional Scope
1.1.3 Estimates And Forecast Timeline
1.2 Research Methodology
1.3 Information Procurement
1.3.1 Purchased Database
1.3.2 GVR’s Internal Database
1.3.3 Secondary Sources
1.3.4 Primary Research
1.3.5 Details Of Primary Research
1.4 Information Or Data Analysis
1.4.1 Data Analysis Models
1.5 Market Formulation & Validation
1.6 Model Details
1.6.1 Commodity Flow Analysis
1.6.1.1 Approach 1: Commodity Flow Approach
1.6.1.2 Approach 2: Country-Wise Market Estimation Using Bottom-Up Approach
1.6.1.3 Approach 2: Country-Wise Market Estimation Using Top-Down Approach
1.7 Global Market: Cagr Calculation
1.8 List Of Secondary Sources
1.9 Objectives
1.9.1 Objective 1:
1.9.2 Objective 2:
1.10 List Of Abbreviations
Chapter 2 Substance Abuse Treatment Market: Executive Summary
2.1 Market Snapshot
2.2 Segment Snapshot
2.3 Competitive Landscape Snapshot
Chapter 3 Substance Abuse Treatment Market: Industry Outlook
3.1 Market Lineage Outlook
3.1.1 Parent Market Lineage Outlook
3.1.2 Related/Ancillary Market Outlook
3.2 Penetration & Growth Prospect Mapping
3.3 Market Dynamics
3.3.1 Market Drivers
3.3.1.1 Increased Number Of Addicted Population
3.3.1.2 Rising Drug Awareness Campaigns And Prevention Programs
3.3.1.3 Increasing Number Of Treatment Centers
3.3.2 Market Restraint Analysis
3.3.2.1 Discontinuation Of Therapies Leading To Relapse Of Addiction
3.3.2.2 High Reluctance To Access Treatment Methods And Poor Treatment Compliance In Some Countries
3.3.3 Market Opportunity Analysis
3.3.3.1 Nicotine Replacement Treatment
3.4 Swot Analysis, By Factor (Political & Legal, Economic And Technological)
3.5 Industry Analysis – Porter’s
3.6 Reimbursement & Regulatory Scenario
3.7 Major Deals & Strategic Alliances
3.7.1 New Product Launch
3.7.2 Acquisition
3.7.3 Expansion
3.7.4 Partnerships
3.7.5 Marketing & Promotions
Chapter 4 Substance Abuse Treatment Market: Competitive Landscape
4.1 Recent Developments & Impact Analysis, By Key Market Participants
4.1.1 Ansoff Matrix
4.2 Company Categorization
4.2.1 Innovators
4.2.1.1 Market Differentiators
4.3 Vendor Landscape
4.3.1 List Of Key Distributors And Channel Partners
4.3.2 Key Customers
4.3.3 Key Company Market Share Analysis, 2022
4.4 Public Companies
4.4.1 Competitive Dashboard Analysis
4.5 Private Companies
4.5.1 List Of Key Emerging Companies
4.6 Regional Network Map
Chapter 5 Substance Abuse Treatment Market: Treatment Type Business Analysis
5.1 Definition And Scope
5.2 Treatment Type Market Share Analysis, 2022 & 2030
5.3 Global Substance Abuse Treatment Market, By Treatment Type, 2018 To 2030
5.4 Substance Abuse Treatment Market: Treatment Type Movement Analysis
5.5 Tobacco/Nicotine & Vaping
5.5.1 Tobacco/Nicotine & Vaping Market Estimates And Forecast, 2018 – 2030 (USD Million)
5.6 Alcohol
5.6.1 Alcohol Market Estimates And Forecast, 2018 – 2030 (USD Million)
5.7 Marijuana
5.7.1 Marijuana Market Estimates And Forecast, 2018 – 2030 (USD Million)
5.8 Synthetic Cannabinoids
5.8.1 Synthetic Cannabinoids Market Estimates And Forecast, 2018 – 2030 (USD Million)
5.9 Prescription & Over-The-Counter Medications
5.9.1 Prescription & Over-The-Counter Medications Market Estimates And Forecast, 2018 – 2030 (USD Million)
5.10 Others
5.10.1 Others Market Estimates And Forecast, 2018 – 2030 (USD Million)
Chapter 6 Substance Abuse Treatment Market: End-Use Business Analysis
6.1 Definition And Scope
6.2 Therapy Market Share Analysis, 2022 & 2030
6.3 Global Substance Abuse Treatment Market, By End-Use, 2018 To 2030
6.4 Substance Abuse Treatment Market: End-Use Movement Analysis
6.5 Hospitals
6.5.1 Hospitals Market Estimates And Forecast, 2018 – 2030 (USD Million)
6.6 Clinics
6.6.1 Clinics Market Estimates And Forecast, 2018 – 2030 (USD Million)
6.7 Rehabilitation Centers
6.7.1 Rehabilitation Centers Market Estimates And Forecast, 2018 – 2030 (USD Million)
6.8 Others
6.8.1 Others Market Estimates And Forecast, 2018 – 2030 (USD Million)
Chapter 7 Substance Abuse Treatment Market: Regional Business Analysis
7.1 Definition & Scope
7.2 Regional Market Share Analysis, 2022 & 2030
7.3 Regional Market Dashboard
7.4 Regional Market Snapshot
7.5 Swot Analysis, By Factor (Political & Legal, Economic And Technological)
7.5.1 North America
7.5.2 Europe
7.5.3 Asia Pacific
7.5.4 Latin America
7.5.5 MEA
7.6 Market Size, & Forecasts, Trend Analysis, 2022 To 2030
7.7 North America
7.7.1 North America Substance Abuse Treatment Market Estimates And Forecast, 2018 – 2030 (USD Million)
7.7.2 U.S.
7.7.2.1 U.S. Substance Abuse Treatment Market, 2018 – 2030 (USD Million)
7.7.2.2 Key Country Dynamics
7.7.2.3 Regulatory Framework
7.7.2.4 Competitive Scenario
7.7.3 Canada
7.7.3.1 Canada Substance Abuse Treatment Market, 2018 – 2030 (USD Million)
7.7.3.2 Key Country Dynamics
7.7.3.3 Regulatory Framework
7.7.3.4 Competitive Scenario
7.8 Europe
7.8.1 Europe Substance Abuse Treatment Market, 2018 – 2030 (USD Million)
7.8.2 U.K.
7.8.2.1 U.K. Substance Abuse Treatment Market, 2018 – 2030 (USD Million)
7.8.2.2 Key Country Dynamics
7.8.2.3 Regulatory Framework
7.8.2.4 Competitive Scenario
7.8.3 Germany
7.8.3.1 Germany Substance Abuse Treatment Market, 2018 – 2030 (USD Million)
7.8.3.2 Key Country Dynamics
7.8.3.3 Regulatory Framework
7.8.3.4 Competitive Scenario
7.8.4 Spain
7.8.4.1 Spain Substance Abuse Treatment Market, 2018 – 2030 (USD Million)
7.8.4.2 Key Country Dynamics
7.8.4.3 Regulatory Framework
7.8.4.4 Competitive Scenario
7.8.5 France
7.8.5.1 France Substance Abuse Treatment Market, 2018 – 2030 (USD Million)
7.8.5.2 Key Country Dynamics
7.8.5.3 Regulatory Framework
7.8.5.4 Competitive Scenario
7.8.6 Italy
7.8.6.1 Italy Substance Abuse Treatment Market, 2018 – 2030 (USD Million)
7.8.6.2 Key Country Dynamics
7.8.6.3 Regulatory Framework
7.8.6.4 Competitive Scenario
7.8.7 Norway
7.8.7.1 Norway Substance Abuse Treatment Market, 2018 – 2030 (USD Million)
7.8.7.3 Regulatory Framework
7.8.7.4 Competitive Scenario
7.8.8 Denmark
7.8.8.1 Denmark Substance Abuse Treatment Market, 2018 – 2030 (USD Million)
7.8.8.2 Key Country Dynamics
7.8.8.3 Regulatory Framework
7.8.8.4 Competitive Scenario
7.8.9 Sweden
7.8.9.1 Sweden Substance Abuse Treatment Market, 2018 – 2030 (USD Million)
7.8.9.2 Key Country Dynamics
7.8.9.3 Regulatory Framework
7.8.9.4 Competitive Scenario
7.9 Asia Pacific
7.9.1 Asia Pacific Substance Abuse Treatment Market, 2018 – 2030 (USD Million)
7.9.2 Japan
7.9.2.1 Japan Substance Abuse Treatment Market, 2018 – 2030 (USD Million)
7.9.2.2 Key Country Dynamics
7.9.2.3 Regulatory Framework
7.9.2.4 Competitive Scenario
7.9.3 China
7.9.3.1 China Substance Abuse Treatment Market, 2018 – 2030 (USD Million)
7.9.3.2 Key Country Dynamics
7.9.3.3 Regulatory Framework
7.9.3.4 Competitive Scenario
7.9.4 India
7.9.4.1 India Substance Abuse Treatment Market, 2018 – 2030 (USD Million)
7.9.4.2 Key Country Dynamics
7.9.4.3 Regulatory Framework
7.9.4.4 Competitive Scenario
7.9.5 South Korea
7.9.5.1 South Korea Substance Abuse Treatment Market, 2018 – 2030 (USD Million)
7.9.5.2 Key Country Dynamics
7.9.5.3 Regulatory Framework
7.9.5.4 Competitive Scenario
7.9.6 Thailand
7.9.6.1 Thailand Substance Abuse Treatment Market, 2018 – 2030 (USD Million)
7.9.6.2 Key Country Dynamics
7.9.6.3 Regulatory Framework
7.9.6.4 Competitive Scenario
7.9.7 Australia
7.9.7.1 Australia Substance Abuse Treatment Market, 2018 – 2030 (USD Million)
7.9.7.2 Key Country Dynamics
7.9.7.3 Regulatory Framework
7.9.7.4 Competitive Scenario
7.10 Latin America
7.10.1 Latin America Substance Abuse Treatment Market, 2018 – 2030 (USD Million)
7.10.2 Brazil
7.10.2.1 Brazil Substance Abuse Treatment Market, 2018 – 2030 (USD Million)
7.10.2.2 Key Country Dynamics
7.10.2.3 Regulatory Framework
7.10.2.4 Competitive Scenario
7.10.3 Mexico
7.10.3.1 Mexico Substance Abuse Treatment Market, 2018 – 2030 (USD Million)
7.10.3.2 Key Country Dynamics
7.10.3.3 Regulatory Framework
7.10.3.4 Competitive Scenario
7.10.4 Argentina
7.10.4.1 Argentina Substance Abuse Treatment Market, 2018 – 2030 (USD Million)
7.10.4.2 Key Country Dynamics
7.10.4.3 Regulatory Framework
7.10.4.4 Competitive Scenario
7.11 MEA
7.11.1 MEA Substance Abuse Treatment Market, 2018 – 2030 (USD Million)
7.11.2 South Africa
7.11.2.1 South Africa Substance Abuse Treatment Market, 2018 – 2030 (USD Million)
7.11.2.2 Key Country Dynamics
7.11.2.3 Regulatory Framework
7.11.2.4 Competitive Scenario
7.11.3 Saudi Arabia
7.11.3.1 Saudi Arabia Substance Abuse Treatment Market, 2018 – 2030 (USD Million)
7.11.3.2 Key Country Dynamics
7.11.3.3 Regulatory Framework
7.11.3.4 Competitive Scenario
7.11.4 UAE
7.11.4.1 UAE Substance Abuse Treatment Market, 2018 – 2030 (USD Million)
7.11.4.2 Key Country Dynamics
7.11.4.3 Regulatory Framework
7.11.4.4 Competitive Scenario
7.11.5 Kuwait
7.11.5.1 Kuwait Substance Abuse Treatment Market, 2018 – 2030 (USD Million)
7.11.5.2 Key Country Dynamics
7.11.5.3 Regulatory Framework
7.11.5.4 Competitive Scenario
Chapter 8 Substance Abuse Treatment Market: Company Profiling
8.1 Company Profiles
8.1.1 Teva Pharmaceutical Industries Ltd.
8.1.2 Abbott
8.1.3 GSK Plc.
8.1.4 F. Cipla Inc.
8.1.5 Lilly (Eli Lilly And Company)
8.1.6 Novartis Ag
8.1.7 Sun Pharmaceutical Industries Ltd.,
8.1.8 Dr. Reddy’s Laboratories Ltd.,
8.1.9 Viatris Inc.,
8.1.10 AstraZeneca
|
| ※본 조사보고서 [세계의 약물 남용 치료 시장 (2023-2030) : 치료 종류별 (담배/니코틴/VAPE, 알코올), 최종 용도별 (재활 센터, 클리닉, 병원), 지역별] (코드 : GRV23MR038) 판매에 관한 면책사항을 반드시 확인하세요. |
| ※본 조사보고서 [세계의 약물 남용 치료 시장 (2023-2030) : 치료 종류별 (담배/니코틴/VAPE, 알코올), 최종 용도별 (재활 센터, 클리닉, 병원), 지역별] 에 대해서 E메일 문의는 여기를 클릭하세요. |
※당 사이트에 없는 보고서도 취급 가능한 경우가 많으니 문의 주세요!
